Skip Header

 

3 results for uniprot:A8MPR0Drop in citationmapping

Customize display Download...

Page 1 of 1

Aberrant expression of N-acetylglucosaminyltransferase-IVa and IVb (GnT-IVa and b) in pancreatic cancer.

Ide Y., Miyoshi E., Nakagawa T., Gu J., Tanemura M., Nishida T., Ito T., Yamamoto H., Kozutsumi Y., Taniguchi N.

Biochem. Biophys. Res. Commun. 341:478-482(2006) GeneRIF 11282 · UniProtKB (2) · Mapped (3)
analysis of expression of N-acetylglucosaminyltransferase-IVa and IVb (GnT-IVa and b) in pancreatic cancer GeneRIF 11282

Kinetic properties and substrate specificities of two recombinant human N-acetylglucosaminyltransferase-IV isozymes.

Oguri S., Yoshida A., Minowa M.T., Takeuchi M.

Glycoconj. J. 23:473-480(2006) GeneRIF 11282 · UniProtKB (2) · Mapped (3)
GnT-IVa is more active than GnT-IVb under physiological conditions and it primarily contributes to the biosynthesis of N-glycans. GeneRIF 11282

N-glycan alterations are associated with drug resistance in human hepatocellular carcinoma.

Kudo T., Nakagawa H., Takahashi M., Hamaguchi J., Kamiyama N., Yokoo H., Nakanishi K., Nakagawa T., Kamiyama T., Deguchi K. et al.

Mol. Cancer 6:32-32(2007) GeneRIF 11282 · Mapped (16)
We investigated mRNA levels of glycosyltransferases namely N-acetylglucosaminyltransferase a (GnT)-IVb and found that (GnT)-IVb expression was increased in HLE-cells Epirubicin resistant. GeneRIF 11282

Page 1 of 1